Journal article
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis
Abstract
BACKGROUND: Cardiovascular comorbidities are frequent in patients with idiopathic pulmonary fibrosis (IPF), and many patients with IPF receive treatment with statins to reduce cardiovascular risk.
OBJECTIVES: We investigated whether statin use at baseline was associated with differences in disease progression in placebo-treated patients or influenced the treatment effect of nintedanib in the INPULSIS® trials.
Authors
Kreuter M; Costabel U; Richeldi L; Cottin V; Wijsenbeek M; Bonella F; Bendstrup E; Maher TM; Wachtlin D; Stowasser S
Journal
Respiration, Vol. 95, No. 5, pp. 317–326
Publisher
Karger Publishers
Publication Date
2018
DOI
10.1159/000486286
ISSN
0025-7931